Izrael - angličtina - Ministry of Health

rafa laboratories ltd - morphine sulfate - tablets controlled release - morphine sulfate 100 mg - morphine - morphine - prolonged relief of severe pain.

Izrael - angličtina - Ministry of Health

lundbeck israel ltd. - sertindole - film coated tablets - sertindole 4 mg - sertindole - sertindole - for the treatment of schizophrenia. due to cardiovascular safety concerns serntidole should only be used for patients intolerant to at least one other anti-psychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Izrael - angličtina - Ministry of Health

lundbeck israel ltd. - sertindole - film coated tablets - sertindole 16 mg - sertindole - sertindole - for the treatment of schizophrenia. due to cardiovascular safety concerns serntidole should only be used for patients intolerant to at least one other anti-psychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Izrael - angličtina - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - coated tablets - fluoxetine as hydrochloride 20 mg - fluoxetine - fluoxetine - prizma is indicated for the treatment of depression and obsessive-compulsive disorders (ocd). for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

Izrael - angličtina - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - tablets - fluoxetine as hydrochloride 60 mg - fluoxetine - fluoxetine - prizma is indicated for the treatment of depression and obsessive-compulsive disorders (ocd). for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

Izrael - angličtina - Ministry of Health

abic marketing ltd, israel - citalopram as hydrobromide - film coated tablets - citalopram as hydrobromide 20 mg - selective serotonin reuptake inhibitors - for the treatment of states of depression and panic disorder.

Izrael - angličtina - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 25 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).

Izrael - angličtina - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eplerenone - film coated tablets - eplerenone 50 mg - eplerenone - inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (lvef < or = 40 % ) and clinical evidence of heart failure after recent myocardial infarction.inspra is indicated in addition to standard optimal therapy, to reduce the risk of cardiovascular morbidity and mortality in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef < or = 30%).

Izrael - angličtina - Ministry of Health

unipharm ltd, israel - valsartan - tablets - valsartan 160 mg - valsartan - for treatment of hypertension. valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalizations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

Izrael - angličtina - Ministry of Health

unipharm ltd, israel - valsartan - tablets - valsartan 80 mg - valsartan - for treatment of hypertension.valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalizations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.